Should you buy NIB Holdings Limited or Medibank Private Ltd?

The Medibank Private Ltd IPO could open up a buying opportunity for NIB Holdings Limited (ASX:NHF) shares.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Shares of NIB Holdings Limited (ASX: NHF) were sold down heavily on Monday but have recovered most of their losses early in today's session to be trading at $3.15. The fluctuating share price can likely be attributed to the pending float of Medibank Private Ltd (ASX: MPL) which will occur on Tuesday at noon.

Medibank Private is Australia's largest health insurer and is being sold for a massive $5.7 billion by the Federal Government. Given the enormous level of interest that the float has received, the stock is likely to begin trading anywhere between $2.15 and $2.40 today, which will deliver retail investors with an immediate paper profit between 7.5% and 20%.

However, even if it were to open at the lower end of that spectrum at $2.15, it will be trading on a lofty P/E ratio of roughly 23 times forecast earnings. While that price could be justifiable if management proves able to drastically reduce costs and improve margins over the coming 12 months, it certainly seems like a tough task.

On the other hand, NIB Holdings, Australia's only other listed health insurer, is trading on a projected P/E ratio of roughly 18.5 times forecast earnings, yet it could offer significantly greater growth prospects given its smaller size. Should the share price of Medibank Private skyrocket today or in the days to follow, investors could certainly decide to lock in their profits and switch into NIB Holdings instead.

Whatever happens, it is very possible that both companies' share prices will remain volatile in the coming days.

NEW: The Motley Fool's #1 Stock for 2015 – Yours FREE!

Instead of potentially overpaying for a stake in Medibank Private, investors should consider the other opportunities that are largely being overlooked by the broader share market.

Motley Fool contributor Ryan Newman does not own shares in any of the companies mentioned.

More on ⏸️ Investing

A white and black robot in the form of a human being stands in front of a green graphic holding a laptop and discussing robotics and automation ASX shares
Technology Shares

Joining the revolution: How I'd invest in ASX AI shares right now

Advances in artificial intelligence (AI) could usher in a new industrial revolution. Here’s how you can invest in it.

Read more »

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »